No Pauses For Pagoclone: Indevus Moving To Phase III For Stuttering
This article was originally published in The Pink Sheet Daily
Executive Summary
The anxiolytic would be the first drug indicated for the condition.
You may also be interested in...
Indevus Rides High On Double Good News
No new trials for testosterone therapy, FDA says; separate Teva deal sweetens the pot.
Indevus Rides High On Double Good News
No new trials for testosterone therapy, FDA says; separate Teva deal sweetens the pot.
Indevus Gains Supprelin LA With Purchase Of Valera
Indevus also expects to out-license Valera's early stage pipeline, as well as several of its own products.